This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site



Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyOff-contract claimsAlliance Healthcare

Example content

About ATTR-CMAbout

Learn about ATTR-CM and uncover the differences between hereditary and wild-type ATTR-CM

About ATTR-CMWhat is ATTR-CM?The different types of ATTR-CM




Example of description text sitting alongside header

Diagnosis of ATTR-CMSigns and symptomsClinical cluesFormal diagnosis
Emerging treatmentsEducational resourcesEducational resources

Explore a range of educational resources to support the diagnosis of ATTR-CM

Educational resourcesExpert VideosDownloadable ResourcesOn Demand Congresses
Support & ResourcesVideosMaterials

Click here for Vyndaqel®▼ (tafamidis) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.

Recognising signs and symptoms of ATTR-CM

The diagnosis of ATTR-CM is often delayed or missed, resulting in an underdiagnosed cause of heart failure with preserved ejection fraction (HFpEF). Wild-type ATTR-CM accounts for 13-17% of HFpEF cases.1,2

  • In an ex-US study of 120 HFpEF patients 60 years or older, wild-type ATTR was confirmed in 13% (13.3%; 95% CI: 7.2–19.5) of the patients1
  • In a US study of 441 autopsied patients, 109 of whom had HFpEF, cardiac wild-type ATTR deposits were found in 17% of the patients2

Patients with wild-type ATTR and hereditary ATTR present with heart failure, particularly HFpEF and other cardiac symptoms.3-5

I Cardiac

  • Fatigue
  • Shortness of breath
  • Oedema
  • Arrhythmias
  • Heart failure with preserved ejection fraction (HFpEF)
  • Aortic stenosis
  • Orthostatic hypotension
  • Erectile dysfunction

| Soft tissue

    • Lumbar stenosis
    • Ruptured distal biceps tendon
    • Eye involvement – glaucoma, intravitreal deposition, scalloped pupils

    I GI

    • Diarrhoea
    • Constipation
    • Nausea
    • Early satiety

    | Neurologic

    • Bilateral carpal tunnel syndrome (CTS)
    • Sensory-motor polyneuropathy
    • Weakness
    Building the knowledge: One disease with many faces

    This is a series of animated, educational modules that outline key background information on ATTR amyloidosis. This video breaks down the various types of ATTR amyloidosis and the clinical clues that can raise suspicion of ATTR-CM.

    Consider the clinical clues and need for further testing Learn more LoadingSee other educational resources available Explore more Loading
    Reference:González-López E, Gallego-Delgado M, Guzzo-Merello G, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015; 36(38): 2585–2594. Mohammed SF, Mirzoyev SA, Edwards WD et al. Left ventricular amyloid deposition in patients with heart failure and preserved ejection fraction. JACC Heart Fail. 2014; 2(2): 113–122Connors LH, Sam F, Skinner M et al. Heart Failure Due to Age-Related Cardiac Amyloid Disease Associated With Wild-Type Transthyretin: A Prospective, Observational Cohort Study. Circulation. 2016; 133(3): 282–290.Maurer MS, Hanna M, Grogan M, et al. Genotype and Phenotype of Transthyretin Cardiac Amyloidosis. J Am Coll Cardiol. 2016; 68(2): 161–172.González-López E, López-Sainz Á, Garcia-Pavia P. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope. Rev Esp Cardiol (Engl Ed). 2017;70(11):991‐1004.Nativi-Nicolau J, Maurer MS. Amyloidosis cardiomyopathy: update in the diagnosis and treatment of the most common types. Curr Opin Cardiol. 2018; 33(5): 571–579.Sperry BW, Reyes BA, Ikram A et al. Tenosynovial and Cardiac Amyloidosis in Patients Undergoing Carpal Tunnel Release. J Am Coll Cardiol. 2018; 72(17): 2040-2050. Geller HI, Singh A, Alexander KM et al. Association Between Ruptured Distal Biceps Tendon and Wild-Type Transthyretin Cardiac Amyloidosis. JAMA. 2017; 318(10): 962–963.Galat A, Guellich A, Bodez D et al. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg? Eur Heart J. 2016; 37(47): 3525–3531.Yanagisawa A, Ueda M, Sueyoshi T et al. Amyloid deposits derived from transthyretin in the ligamentum flavum as related to lumbar spinal canal stenosis. Mod Pathol. 2015; 28(2): 201–207.Witteles RM, Bokhari S, Damy T et al. Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice. JACC Heart Fail. 2019; 7(8): 709–716.
    PP-VYN-GBR-0888. October 2021
    Quick Links
    View a range of educational resources to support the diagnosis of ATTR-CM

    Listen to our faculty of expert speakers and download resources including our interactive ATTR-CM Red Flags guide. You can also access and sign up to upcoming virtual events. 

    Explore Educational ResourcesLoading

    PP-VYN-GBR-1007. September 2022

    Register to receive tailored marketing information from Pfizer by email

    Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.​​​​​​​

    Sign up nowLoading

    ​​​​​​PP-PFE-GBR-2809. October 2020

    Adverse events should be reported. Reporting forms and information can be found at or search 

    for MHRA Yellow Card in Google Play or Apple App Store

    Adverse events should also be reported to Pfizer Medical Information on 01304 616161

    PfizerPro Account

    To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

    Sign In or RegisterAccountSign Out

    This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit


    This website is brought to you by Pfizer Limited, a company registered in England 

    and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ


    Copyright © 2023 Pfizer Limited. All rights reserved.


    VAT registration number GB201048427

    PP-UNP-GBR-4885. May 2023
    For UK Healthcare Professionals*

    These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

    I confirm that I am a healthcare professional* resident in the United Kingdom.

    If you select 'No', you will be redirected to where you will be able to access reference information on Pfizer's prescription medicines.

    *The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

    PP-PFE-GBR-3863. November 2021

    You are now leaving PfizerPro​​​​​

    ​​​​​​​You are now leaving Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

    Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

    ​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
    You are now leaving PfizerPro
    ​​​​​​​You are now leaving Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

    Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
    business which it has provided or reviewed.

    PP-PFE-GBR-3859. November 2021